Cardinal Health (CAH) Stock Price, News & Analysis

Company Overview

Cardinal Health is a healthcare services and products company that distributes pharmaceuticals and medical supplies. Its customers include pharmacies, hospitals, surgery centers, physician offices and other healthcare providers.

The company’s businesses include pharmaceutical distribution and specialty services, as well as the sourcing and distribution of medical and surgical products. Its offerings support areas such as specialty medications, medication management and supply-chain operations.

Cardinal Health traces its roots to a wholesale business founded in Ohio in 1971 and later expanded into pharmaceutical distribution. It serves customers primarily in the United States, with operations and customers in other markets as well.

Key Stats

• Today's Range: $263.92 to $272.99
• 50-Day Range: $220.12 to $270.99
• 52-Week Range: $180.45 to $286.29
• Volume: 1.98 million shs
• Average Volume: 1.83 million shs
• Market Capitalization: $62.75 billion
• P/E Ratio: 35.06
• Dividend Yield: 0.76%
• Price Target: $272.50
• Consensus Rating: Moderate Buy

Cardinal Health Stock Analysis - MarketRank™

Cardinal Health scored higher than 66% of companies evaluated by MarketBeat, and ranked 270th out of 886 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.5 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Cardinal Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.84, and is based on no strong buy ratings, 16 buy ratings, 3 hold ratings, and no sell ratings.

Upside/Downside

The consensus price target for Cardinal Health is close to its current price, suggesting limited near-term upside or downside.

Amount of Analyst Coverage

Cardinal Health has been the subject of 12 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: 9.33%

Earnings Growth

Earnings for Cardinal Health are expected to grow by 9.33% in the coming year, from $12.86 to $14.06 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Cardinal Health is 35.06, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 26.46.

Price to Earnings Ratio vs. Sector

The P/E ratio of Cardinal Health is 35.06, which means that it is trading at a more expensive P/E ratio than the Healthcare sector average P/E ratio of about 34.53.

Price to Earnings Growth Ratio

Cardinal Health has a PEG Ratio of 1.63. PEG Ratios above 1 indicate that a company could be overvalued.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

3.32% of the float of Cardinal Health has been sold short.

Short Interest Ratio / Days to Cover

Cardinal Health has a short interest ratio ("days to cover") of 4.99.

Change versus previous month

Short interest in Cardinal Health has recently increased by 4.19%, indicating that investor sentiment is decreasing.

Dividend

• Score: 3.3 / 5
• Dividend Strength: Strong

Dividend Yield

Cardinal Health has a dividend yield of 0.76%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Cardinal Health has been increasing its dividend for 29 years.

Dividend Coverage

The dividend payout ratio of Cardinal Health is 28.49%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Cardinal Health will have a dividend payout ratio of 14.65% next year. This indicates that Cardinal Health will be able to sustain or increase its dividend.

News and Social Media

• Score: 3.6 / 5
• News Sentiment: 0.76

News Sentiment

Cardinal Health has a news sentiment score of 0.76. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.38 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 45 news articles for Cardinal Health this week, compared to 7 articles on an average week.

Search Interest

Only 10 people have searched for CAH on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

MarketBeat Follows

17 people have added Cardinal Health to their MarketBeat watchlist in the last 30 days. This is an increase of 113% compared to the previous 30 days.

Company Ownership

• Score: 1.4 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Cardinal Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $49,626,657.00 in company stock.

Percentage Held by Insiders

0.12% of the stock of Cardinal Health is held by insiders.

Percentage Held by Institutions

87.17% of the stock of Cardinal Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Record date for 10/15 Dividend: 10/01/2026
• Ex-Dividend for 10/15 Dividend: 10/01/2026
• Dividend Payable: 10/15/2026
• Last Earnings: 11/05/2026
• Today: 11/08/2026
• Fiscal Year End: 6/30/2027

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Distributors
• Current Symbol: NYSE:CAH
• CIK: 721371
• Web: www.cardinalhealth.com
• Phone: (614) 757-5000
• Fax: 614-757-6000
• Employees: 63,900
• Year Founded: 1971

Price Target and Rating

• Average Price Target for Cardinal Health: $272.50
• High Price Target: $295.00
• Low Price Target: $208.00
• Potential Upside/Downside: +0.6%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.84
• Research Coverage: 19 Analysts

Profitability

• EPS (Trailing Twelve Months): $7.23
• Trailing P/E Ratio: 35.06
• Forward P/E Ratio: 19.27
• P/E Growth: 1.63
• Net Income: $1.71 billion
• Net Margins: 0.71%
• Pretax Margin: 0.88%
• Return on Equity: -102.72%
• Return on Assets: 4.86%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.88
• Quick Ratio: 0.49

Sales & Book Value

• Annual Sales: $254.25 billion
• Price / Sales: 0.25
• Cash Flow: $15.42 per share
• Price / Cash Flow: 17.57
• Book Value: ($12.38) per share
• Price / Book: -21.89

Miscellaneous

• Outstanding Shares: 231,560,000
• Free Float: 231,281,000
• Market Cap: $62.75 billion
• Optionable: Optionable
• Beta: 0.53